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Two processes, DNA replication andDNAdamage repair, are
key to maintaining genomic fidelity. The Dna2 enzyme lies at
the heart of both of these processes, acting in conjunction with
flap endonuclease 1 and replication protein A in DNA lagging
strand replication and with BLM/Sgs1 and MRN/X in double
strand break repair. In vitro, Dna2 helicase and flap endo/exo-
nuclease activities require an unblocked 5 single-stranded
DNA end to unwind or cleave DNA. In this study we character-
ize aDna2nuclease activity that does not require, and in fact can
create, 5 single-stranded DNA ends. Both endonuclease and
flap endo/exonuclease are abolished by the Dna2-K677R muta-
tion, implicating the same active site in catalysis. In addition, we
define a novel ATP-dependent flap endo/exonuclease activity,
which is observed only in the presence of Mn2. The endonu-
clease is blocked byATP and is thus experimentally distinguish-
able from the flap endo/exonuclease function. Thus,Dna2 activ-
ities resemble those of RecB and AddAB nucleases even more
closely than previously appreciated. This work has important
implications for understanding the mechanism of action of
Dna2 inmultiprotein complexes, where dissection of enzymatic
activities and cofactor requirements of individual components
contributing to orderly and precise execution of multistep rep-
lication/repair processes depends on detailed characterization
of each individual activity.
The Dna2 protein is an essential enzyme involved in both
Okazaki fragment processing and double strand break (DSB)4
repair (1–5). The conserved Dna2 enzymatic activities, single-
stranded DNA (ssDNA)-dependent ATPase, 5-3 helicase,
5-3 endo/exonuclease, 3-5 exonuclease, single strand
annealing, and strand exchange, function in DNA replication
and DSB repair in both the nucleus and mitochondria of yeast
and human cells (6–16). Genetic and biochemical studies have
shown yeast, Xenopus, and human Dna2 nuclease to function
with Sgs1/BLM helicase and the MRX-MRN complex in the 5
end resection of DSBs and with flap endonuclease 1 (FEN1),
replication protein A (RPA), and Ctf4 in lagging strand DNA
replication (11, 12, 17–27). Given its key roles in these two
important pathways and its multiplicity of biochemical func-
tions, it is of interest to characterize further the unique enzy-
matic functions and substrate preferences of the Dna2 enzyme
that underlie these physiological processes.
The preference of Dna2 for ssDNA flaps, such as 5-termi-
nated tails generated during strand displacement synthesis by
polymerase  duringOkazaki fragment processing, is evident in
binding and enzymatic studies (28, 29). The helicase activity of
Dna2 requires a free 5 ssDNAend to unwindDNA, and the flap
endo/exonuclease activity requires an unblocked 5 end to
cleave flap structures (30, 31). Although the DNA end is neces-
sary to stimulate the flap nuclease activity, cleavage occurs
within the flap up to 6–7 nucleotides from the ssDNA/dsDNA
junction making the reaction technically endonuclease (2, 32).
This function is termed flap endo/exonuclease in this study
consistent with other proteins that have similar modes of
action. DNA fork structures or ssDNA flap structures (single-
stranded tails at a nick or gap in duplexDNA) compete forDna2
binding more effectively than nicked duplex or ssDNA gap
regions, showing that Dna2 is a structure-specific enzyme (29).
This binding is independent of the free end required for nucleo-
lytic cleavage, because Dna2 can bind to a DNA fork or flap
when the 5 end is blocked, even though its nuclease activity
cannot cleave the structure (18, 28).
The purpose of the DNA end is of considerable interest in
understanding how Dna2 functions in the cell. The Dna2
enzyme is proposed to initially bind to the ssDNA/dsDNA
junction and then track down the flap from the free end. Evi-
dence for this model comes from experiments with a blockage
in themiddle of the flap that results in cleavage between the end
and the blockage point but not beyond the block toward the
base of the flap (31). One unique role of Dna2 is to remove long
flaps that are coated by the ssDNA-binding protein RPA
because these structures cannot be removed by FEN1 during
Okazaki fragment processing (18, 33, 34). Interestingly, yeast
Dna2 can displace RPA from flaps with blocked 5 ends, even
though Dna2 cannot track down the length of the blocked flap
(33).
These observations have led us to investigate further the
requirement for free ends in Dna2 activity. In this study, we
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characterizeDna2 endonuclease activity in the absence ofDNA
ends (32). We show that Dna2 can bind circular ssDNA and
cleave it, but that, in contrast to previous results, circular DNA
is not an effector of the ATPase activity (35). We also find that
the endonuclease and the flap endo/exonuclease are catalyzed
by the same active site, but that, nevertheless, the activities are
distinguishable based on their cofactor requirements. The pres-
ence of this endonuclease function allows the Dna2 enzyme to
create free ends for further helicase and flap endo/exonuclease
processing, which might be encountered during repair of DSBs
with ends modified by proteins or terminating in modified
nucleotides.
EXPERIMENTAL PROCEDURES
Materials and Substrates—M13mp18 and X174 phage
ssDNAwas purchased fromNewEnglandBiolabs. All synthetic
oligonucleotides were purchased from Integrated DNA Tech-
nologies. Oligonucleotide sequences are listed in Table 1.
[-32P]ATP, 10 mCi/ml, was purchased fromMP Biomedicals.
The 5 oligonucleotide labeling reactions were performed as
described previously with T4 polynucleotide kinase and
[-32P]ATP (36). For annealing to M13mp18, oligonucleotides
were placed in TE (1 mM EDTA and 10 mM Tris-HCl (pH 8.0)),
heated to 100 °C for 5 min and slowly cooled to room temper-
ature. Yeast RPA was purified as described (37).
Dna2 Protein Purification—Human Dna2 was purified as
described previously (6).Wild-type and nuclease-dead (K677R)
Saccharomyces cerevisiae Dna2 proteins were expressed in
yeast grown in 2 liters of minimal medium without uracil sup-
plemented with 2% glycerol, 3% lactic acid, and 3% galactose.
Cells were lysed using a CryoMill (Retsch) with continuous liq-
uid nitrogen cooling. Pellets were resuspended in 50 ml of 20
mM Tris-HCl (pH 8.0), 35 mM imidazole, 750 mM NaCl, 5%
glycerol (v/v), 1 mM 2-mercaptoethanol, 0.01% Triton X-100,
and Complete EDTA-free protease inhibitor mixture (Roche
Applied Science). Extracts were clarified by ultracentrifugation
at 29,000 rpm for 20 min in a Beckman Ti-45 rotor. The super-
natant was mixed with 2 ml of Ni2-nitrilotriacetic acid-aga-
rose (Qiagen) for 1 h at 4 °C. Resin was collected by gravity flow
andwashed three times with 20ml of 20mMTris-HCl (pH 8.0),
35 mM imidazole, 5% glycerol, 1 mM 2-mercaptoethanol buffer
containing decreasing levels of NaCl (750mM, 300mM, and 100
mMNaCl, respectively). Dna2 was eluted in 1-ml fractions of 20
mM Tris-HCl (pH 8.0), 400 mM imidazole, 5% glycerol, 1 mM
2-mercaptoethanol, and 100 mM NaCl. Fractions containing
Dna2 were pooled and loaded onto a 1-ml MonoQ FPLC col-
umn (GE Healthcare) equilibrated with MonoQ buffer (25 mM
Tris-HCl (pH 7.5), 10% glycerol, 100 mM NaCl, 1 mM EDTA).
The column was washed with 10 ml of MonoQ buffer and
eluted over a 10-ml gradient of 100–600 mM NaCl. Fractions
containing Dna2 were pooled and dialyzed into storage buffer
containing 25 mM Tris-HCl (pH 7.5), 500 mM NaCl, 25% glyc-
erol, and 1 mM EDTA. Aliquots were stored at80 °C.
Endonuclease Assay with Circular ssDNA—Nuclease reac-
tions containing 50 fmol of Dna2 protein, 500 ng of M13mp18
or X174 circular ssDNA, and MgCl2, MnCl2, and ATP as
noted in the figures and figure legends in 20 l of reaction
buffer (50mMTris-HCl (pH7.5), 25mMNaCl, 2mMdithiothre-
itol (DTT), 0.25 mg/ml bovine serum albumin (BSA)) were
incubated at 37 °C for 15 min. Reactions were stopped by the
addition 5 buffer (60 mM EDTA, 40% sucrose, 0.6% SDS,
0.25% bromphenol blue, and 0.25% xylene cyanole FF) and elec-
trophoresed on a 1% agarose gel containing ethidium bromide.
Reactions includingRPA, 0.75g or 1.5g,were first incubated
in reaction buffer (25mMTris-HCl (pH 7.5), 25mMNaCl, 2mM
DTT, 0.25 mg/ml BSA, 1 mM MgCl2 or MnCl2, and 100 ng of
M13mp18) minus Dna2 for 10 min at room temperature to
facilitate RPA-ssDNAbinding. 50 fmol ofDna2was then added,
and reactions were incubated at 37 °C for 15 min.
Electrophoretic Mobility Shift Assay with Competitor—Reac-
tions, mixed on ice, contained 1 pmol of nuclease-dead Dna2-
K677R and 20 fmol of 32P-labeled 5 flap substrate in 20 l of
reaction buffer (25 mM Tris-HCl (pH 7.5), 2 mM DTT, 0.5
mg/ml BSA, 2 mM ATP, 5% glycerol, and 1 mM or 2 mM MgCl2
as indicated). Unlabeled competitors, M13mp18 circular
ssDNA, and 5 flap substrate were added as indicated, and reac-
tions were incubated at 30 °C for 20min. Samples were electro-
phoresed on a 12%polyacrylamide gel at 4 °C, 100V for 3 hwith
0.5 TBE running buffer (89 mM Tris, 89 mM boric acid, and 2
mM EDTA), and products were detected by PhosphoImager.
ATPase Assay—ATPase reactions containing 1 pmol of wild-
type or nuclease-dead Dna2 protein in 20 l of reaction buffer
(40 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 25 mM NaCl, 1 mM
DTT, 0.5 mg/ml BSA, 0.2 mM ATP, 10% glycerol, and 3 Ci of
[-32P]ATP) were supplemented with 15.625 ng, 62.5 ng. 250
ng, or 1g of ssDNA (M13mp18 ssDNA circle and 5-flap sub-
strate as indicated) and incubated at 30 °C for 1 h. The reactions
were stopped by adding EDTA to a final concentration of 4mM.
0.8 l of each reaction was spotted onto a polyethyleneimine-
cellulose TLC plate (Selecto Scientific) and developed in 0.5 M
LiCl, 1 M formic acid solution. Products were detected by
PhosphoImager.
Exonuclease Assay with Radiolabeled Substrate—Nuclease
reactions containing 50 fmol of Dna2 protein, 20 fmol of radio-
labeled substrate, andMgCl2,MnCl2, andATP as noted in 20l
of reaction buffer (50mMTris-HCl (pH 7.5), 25mMNaCl, 2mM
DTT, 0.25 mg/ml BSA) were incubated at 37 °C for 15 min.
TABLE 1
Oligonucleotides used in this study
Oligonucleotides Length Sequence
nt
5 Flap 98 TTCACGAGATTTACTTATTTCACTGCGGCTACATGATGCATCGTTAGGCGATTCCGCCTAACGATGCATCATGTCGCGA
ACCCTATTTAGGGTTCGCG
5 Tail 74 TTCACGAGATTTACTTATTTCACTGCGGCTACATGATGCATCGTTAGGCGATTCCGCCTAACGATGCATCATGT
H1 (5 flap) 42 AGCTAGCTCTTGATCGTAGACGTTGTAAAACGACGGCCAGTG
H2 (annealed) 24 GACGTTGTAAAACGACGGCCAGTG
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Reactions were stopped by using 2 denaturing termination
dye (95% deionized formamide, 10 mM EDTA, 0.1% bro-
mphenol blue, and 0.1% xylene cyanol), and boiled for 5 min.
The cleavage products were separated on a 12% sequenc-
ing gel (SequaGel; National Diagnostics) and detected by
PhosphoImager.
Endonuclease and Helicase Assays with Radiolabeled Sub-
strate—Standard reactions contained 300 fmol of Dna2 or
Dna2-K677R and 10 fmol of helicase substrates (32P-labeledH1
(5 flap) or H2 (fully annealed) oligonucleotides annealed to
M13mp18) in 20 l of reaction buffer (25 mM Tris-HCl (pH
7.5), 25 mM NaCl, 2 mM DTT, 0.25 mg/ml BSA) with MgCl2,
MnCl2, and ATP as indicated. Reaction buffers with increasing
NaCl contained from 0 to 200mMNaCl as noted. After incuba-
tion at 37 °C for 30 min, reactions were stopped with 5 stop
solution (60 mM EDTA, 40% sucrose, 0.6% SDS, 0.25% bro-
mphenol blue, and 0.25% xylene cyanole FF). Reaction products
were then separated using 8% native polyacrylamide gels con-
taining 0.1% SDS and detected by PhosphoImager.
For endonuclease reactions with yeast RPAusing 32P-labeled
H2 oligonucleotide annealed to M13mp18 as the substrate, 2.5
pmol of RPA/reaction was incubated with 10 fmol of the sub-
strate in 1 reaction buffer for 10 min at room temperature
prior to the addition of yeast Dna2 protein and 1 mMMgCl2 or
1 mM MnCl2 as indicated.
RESULTS
Dna2 Has Endonuclease Activity—Several recent biochemi-
cal studies have demonstrated the requirement for a free 5
DNA end for Dna2 helicase and flap endo/exonuclease activity
on synthetic oligonucleotide substrates (30, 31). However, prior
studies showed that Dna2 has nuclease activity on circular
ssDNA, i.e. DNA entirely without ends (2, 32). To reconcile
these observations, we revisited the endonuclease function of
Dna2. We first asked whether yeast Dna2 could cut a long
ssDNA substrate without an end. For this, we used the circular
ssDNA of phage M13mp18 (M13). Under standard Dna2
nuclease assay conditions, as shown in Fig. 1A, lane 2, the phage
DNA was degraded by Dna2. ATP is known to inhibit the flap
endo/exonuclease activity of Dna2. As shown in Fig. 1A, lane 3,
ATP also protects the circular ssDNA substrate from Dna2
endonuclease activity. A ratio of 1:1 Mg2:ATP significantly
reduces the endonuclease activity of Dna2 (Fig. 1A, lane 4).
Recently, Dna2 has been shown to function in conjunction
withMre11 and Sgs1/Rmi1/Top3 in resection of aDSB. It is not
clear whether the Mre11 is performing a preprocessing event,
such as preliminary resection, or whether its primary role is in
recruiting the Dna2/Sgs1 proteins to the unprocessed break.
The nuclease activity of Mre11 is dependent on Mn2 and is
not supported by Mg2 under most conditions. However,
Mn2, even in the presence ofMg2, inhibits theDSB resection
reaction reconstituted from the human counterparts to the
yeast proteins: MRN, BLM, and DNA2, raising the question of
which protein in the resection reaction is inhibited by Mn2
(12). We found that M13mp18 is completely degraded by yeast
Dna2 in the presence of Mn2 alone as a cofactor (Fig. 1A, lane
5). Addition of ATP at a ratio of 2:1 ATP:Mn2 inhibits the
endonuclease activity (Fig. 1A, lane 6), as it doeswithMg2, but
at a 1:1 ATP:Mn2 ratio, ATP is not sufficient to protect the
M13 circular DNA (lane 7). Endonuclease activity is somewhat
greater withMn2 thanMg2with a circular substrate. Amix-
ture of Mg2 and Mn2 also supported endonuclease activity
(Fig. 1A, lane 8) and was not inhibited by a 1:1 ratio of ATP to
Mg2 andMn2 (lane 9), unlike the reaction withMg2 alone,
suggesting that Mn2 is dominant over Mg2 in supporting
Dna2 endonuclease.
BecauseMn2 does not inhibit, but stimulates Dna2, it is not
Dna2 in the Dna2/BLM/MRN reconstituted resection reaction
that is inhibited by Mn2, although the effects of Mn2 could
be different in the presence of the additional proteins. Similar
endonuclease properties were observed with X174 circular
ssDNA (Fig. 1B). In this case it is clear that the X174 DNA
preparation contained a significant fraction of linear as well as
circular DNA. Both are degraded by Dna2 in the presence of
either Mg2 or Mn2. The contamination of theX174 circu-
lar DNApreparationwith linear DNA, documented by the pro-
FIGURE 1. Dna2 has endonuclease activity. A, nuclease assays were per-
formed as described under “Experimental Procedures.” Briefly, 50 fmol of
yeast Dna2was incubatedwith 500ngofM13mp18phage ssDNAandMgCl2,
MnCl2, and ATP as indicated for 15min at 37 °C. Reaction products were sub-
jected to electrophoresis on a 1% agarose gel, and DNA was stained with
ethidium bromide. B, nuclease reactions were performed as above with
M13mp18 andX174 ssDNA as indicated. C, nuclease assay with M13mp18
ssDNA and Dna2-K677R, nuclease-defective, is shown.
Dna2 Endonuclease and ATP-dependent Endo/Exonuclease
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vider, can explain a previous observation suggesting that the
helicase activity of Dna2 could function in the absence of a free
end for Dna2 loading (35). No endonuclease is observed with
Dna2-K677R, which is endo/exonuclease-defective in the pres-
ence of either Mg2 or Mn2 (Fig. 1C). We conclude that,
unlike Dna2 helicase and flap endo/exonuclease functions,
Dna2 can act as an endonuclease in the absence of a free DNA
end and that the same active site catalyzes both nucleolytic
activities.
Association of Dna2 with ssDNA Does Not Require an End—
We next investigated whether association of Dna2 with ssDNA
required a DNA end. Previous studies have shown that Dna2
can bind to ssDNA flapswith blocked ends, but those substrates
contained ssDNA/dsDNA junctions and other secondary
structures that are strong binding sites for Dna2 (29).We asked
whether circular ssDNAcould competewith a radiolabeled flap
substrate for Dna2 binding as measured by EMSA. To protect
the labeled flap substrate from Dna2 nuclease activity, the
nuclease-deficient Dna2-K677R mutant was used. In Fig. 2,
lane 2, it is clear that Dna2 binds to the flap substrate. Compe-
tition with increasing amounts of unlabeled flap substrate
reduces the amount shifted (Fig. 2, lanes 6–8 and 13–15).
Whenunlabeled circular ssDNAwas added as a competitor, the
amount of flap substrate shifted by Dna2 was also reduced (Fig.
2, lanes 3–5 and 10–12). Therefore, Dna2 does not require a
free DNA end or a flap/fork junction to bind ssDNA. As in the
case of the flap substrate, the binding to the ssDNA circle was
not inhibited by ATP, even though these conditions protect the
circle from Dna2 endonuclease degradation (see Fig. 1). We
conclude that Dna2 can bind toDNAwithout ends and that the
inhibitory effect of high levels of ATP on nuclease activity is not
due to interference with DNA binding.
DNA Ends Are Required to Stimulate Dna2 ATPase Activity—
Dna2 is a ssDNA-dependent ATPase. With wild-type Dna2
protein, the circular ssDNAand linear ssDNApromoteATPase
activity equally (Fig. 3, lanes 10–13 and 14–17). With the
nuclease-deadDna2-K677R protein, however, only linear DNA
serves as anATPase effector (Fig. 3, lanes 1–4), even thoughwe
demonstrated that Dna2-K677R does bind to the circular
ssDNA (Fig. 2).We infer that wild-typeDna2 first linearizes the
circular DNA, which then serves as a Dna2 cofactor. This veri-
fies that DNA ends, not ssDNA alone, are required to stimulate
ATPase activity. This also establishes the fact that the K677R
mutation prevents the generation of these ends, confirming
that the K677R mutation abolishes both endonuclease and flap
endo/exonuclease activities.
Endo- and Exonuclease Activities Can Be Separated—The
strong Dna2 endonuclease activity in the presence of Mn2
promptedus to investigate flap endo/exonuclease activity in the
presence of Mn2. As shown in Fig. 4A, lane 2, yeast Dna2 flap
endo/exonuclease, in the presence of Mg2, removes the 5
ssDNA flap from20 fmol of radiolabeled substrate. This activity
is reduced in the presence of ATP as evidenced by the remain-
ing uncut substrate (Fig. 4A, lane 3). Mn2 cannot substitute
for Mg2 in cutting the 5 flap (Fig. 4A, lane 4). Surprisingly,
however, when Mn2 is supplemented with ATP, the flap
endo/exonuclease activity is restored (Fig. 4A, lane 5). This
ATP-dependent exonuclease activity in the presence of Mn2
stands in direct contrast to theMg2-dependent endonuclease
activity that is inhibited by the presence of ATP.
When Mg2 and Mn2 are present in equal concentrations,
no flap endo/exonuclease is detected, similar to Mn2 alone
(compare Fig. 4A, lanes 4 and 6). When ATP is added to the
reaction withMg2 andMn2 (Fig. 4A, lane 7), the substrate is
cleaved. The inhibition of Mg2-dependent flap endo/exonu-
clease activity byMn2 is puzzling, considering that both cofac-
tors support robust endonuclease activity alone or together.
However, this observation demonstrates that the endonuclease
FIGURE 2.Association ofDna2with ssDNAdoes not require an end. EMSA
was performed as described under “Experimental Procedures.” 32P-Labeled
5 flap substrate was mixed on ice with 1 pmol of Dna2-K677R protein in
reaction buffer supplemented with Mg2Cl and ATP as indicated. Lane 1 con-
tains the substrate in the absence of Dna2 protein. Lanes 2 and 9 indicate
the electrophoretic mobility shift of the substrate with Dna2 protein in the
absence of DNA competitor. Lanes 3–5 and 10–12 show binding of the
labeled substrate in the presence of 2.5, 10, and 100 ng of M13mp18 circular
ssDNA competitor as noted by white triangles. Lanes 6–8 and 13–15 show
binding of the labeled substrate in the presence of 2.5, 10, and 100 ng of
unlabeled 5 flap substrate competitor, as noted by black triangles.
FIGURE 3. DNA ends are required for ATPase activity. ATPase assays were
performed as described under “Experimental Procedures.” Reactions in lanes
1–9were performedwith 1 pmol of nuclease-dead Dna2-K677R. Reactions in
lanes 10–18 were performed with 1 pmol of wild-type Dna2 protein. Lanes
1–4 and 10–13were supplementedwith 15.625 ng, 62.5 ng, 250 ng, and 1g
of M13mp18 circular ssDNA as denoted by white triangles. Lanes 5–8 and
14–17were supplementedwith 15.625ng, 62.5 ng, 250ng, and1gof 5 flap
substrate as denoted by black triangles. Reactions in lanes 9 and 18 lacked
ssDNA.
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and flap endo/exonuclease functions are experimentally sepa-
rable, even though they are both abolished with a mutation at
the same residue in the nuclease active site. We analyzed three
different 5 flap substrates and found that this Mn2-depen-
dent behavior was consistent regardless of the substrate struc-
ture at the ssDNA/dsDNA junction (Fig. 4A).
Comparison of the reaction products in Fig. 4A, especially
between lanes 9 and 12, for the 5 overhang substrate and lanes
16 and 19 for the 5 flap substrate adjacent to an upstream
oligonucleotide, shows the Mn2/ATP-stimulated nuclease
products to be shorter than those observed withMg2 alone. It
is unknown whether this is due to lower processivity along the
flap or secondary cutting after the initial flap removal with
Mn2 andATP. However, similar nuclease assays with 3 labels
on the 5 fork substrate show the final products after bothMg2
and Mn2/ATP mediated cutting to be the same length (data
not shown). The presence ofMn2 does not enable Dna2 to cut
or degrade linear double-stranded DNA (dsDNA), with or
without ATP, consistent with behavior with cofactor Mg2
(data not shown).
All of these activities, including the ATP-dependent, Mn2-
stimulated flap removal activity, were conserved in the human
Dna2 protein (Fig. 4B). As previously reported, human Dna2
does not show nuclease when Mn2 is substituted for Mg2
(Fig. 4B, lanes 4 and 6). However, we now show thatMn2 does
exhibit nuclease activity if ATP is added (Fig. 4B, lanes 5 and 7).
Endonuclease Can Create DNA End for Helicase or Exonu-
clease Activity—It has been recently established that the Dna2
helicase requires a free DNA end to unwind DNA (30). Consid-
ering the end-independent endonuclease activity characterized
above, we wondered whether Dna2 could create a free end suit-
able for its helicase activity. We first measured helicase activity
using the Dna2-K677R mutant and a 5 32P-labeled oligonu-
cleotide with an 18-nucleotide 5 noncomplementary flap
annealed to the M13mp18 circular ssDNA. Helicase products
are generated in the presence of ATP with either Mg2 or
Mn2 but not in the absence of ATP (Fig. 5A, compare lanes 4
and 5 with lanes 2 and 3). Note that the small amount of label
migrating ahead of the oligonucleotide in lane 2 is due tominor
residual exonuclease seen in Dna2-K677R preparations after
extended incubation, but that no endonuclease products, such
as are seen in Fig. 5B, lane 4, are apparent. Although not as
potent as Mg2, we find that Mn2 is a functional cofactor for
Dna2 helicase activity.
In keeping with the demonstration that substrates without a
ssDNA flap or with a flap whose 5 end is blocked by a bulky
adduct cannot be unwound by Dna2, when we annealed an
oligonucleotide lacking a noncomplementary 5 flap to
M13mp18 and incubated with wild-type Dna2 under condi-
tions that inhibit the endonuclease, 1mMMg2 and 2mMATP,
the substrate is not unwound (Fig. 5B, lane 3). This is likely
because there is no free 5 ssDNA tail on the oligonucleotide
and the circle is protected from degradation by the excess ATP
and cannot provide an alternative end.As shown in Fig. 5B, lane
4, when this assay is repeated in conditions that allow some
endonuclease activity, 1 mM Mg2 and 1 mM ATP as estab-
lished in Fig. 1, both endonuclease products and helicase prod-
ucts are seen. Increasing amounts of NaCl have been shown
previously to inhibit the flap endo/exonuclease activity of Dna2
(6, 15, 35). The endonuclease activity was also clearly inhibited
FIGURE 4. Endonuclease and exonuclease functions can be separated.
Nuclease assays were performed as described under “Experimental Proce-
dures” with 50 fmol of yeast Dna2 (A) or humanDna2 (B) protein for 15min at
37 °C. The radiolabeled substrates are depicted under the respective panels
with an asterisk denoting the position of the label: H1 (5 flap) annealed to
M13 phage ssDNA (lanes 1–7), 5 tail with dsDNA hairpin (lanes 8–14), and 5
flapwith dsDNAhairpin (lanes 15–21). Addition of 2mMATP, 2mMMgCl2, and
2 mM MnCl2 is denoted by/marks.
FIGURE 5. Endonuclease activity can generate helicase substrate. A, heli-
case assays were performed as described under “Experimental Procedures”
using nuclease-dead Dna2-K677R and 1 mM MgCl2, 1 mM MnCl2, and 2 mM
ATP as indicated with radiolabeled H1 (5 flap) oligonucleotide annealed to
M13mp18 ssDNA. Reactionswere incubated at 37 °C for 30min, andproducts
were resolved on nondenaturing PAGE. Lane 1 represents the substrate
alone. Helicase reaction products are indicated by the arrow corresponding
to the oligonucleotide alone. Products of residual Dna2 flap endo/exonu-
clease activity in lane 2 are indicated by the nuclease arrow. B, helicase reac-
tions were performed as above using wild-type Dna2 and a radiolabeled H2
(fully annealed) oligonucleotide annealed to M13mp18 ssDNA. Lane 1 con-
tains the substrate alone and lane 2 the substrate after boiling. Helicase prod-
ucts are noted by the arrow corresponding to the labeled oligonucleotide
after boiling. Lanes 4–8 contain increasing concentrations of NaCl from 0 to
200 mM as indicated.
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by increasing NaCl (Fig. 5B, lanes 5–8), and this resulted in a
corresponding reduction of unwound helicase product. These
results led to the conclusion that Dna2 endonuclease can create
a substrate for its helicase activity.
Replication Protein A Inhibits Dna2 Endonuclease Activity—
Several studies have shown that Dna2 enzymatic activity is
modulated by RPA; 5 flap endo/exonuclease activity is stimu-
lated whereas 3 exonuclease activity is inhibited (7, 26, 33).
This regulation is thought to give Dna2 specificity to process
the correct strand of DSB ends and nascent Okazaki fragments.
We were interested to see how RPA affected the Dna2 endonu-
clease function on the M13mp18 circular ssDNA lacking
dsDNA/ssDNA junctions. As shown in Fig. 6A, RPA inhibited
endonucleolytic cleavage of M13 DNA by Dna2 protein in the
presence of either Mg2 (Fig. 6A, lanes 4–6) or Mn2 (Fig. 6A,
lanes 8–10). This result is consistent with the inferred inhibi-
tion of Dna2 endonuclease by RPA on a substrate comprising a
radiolabeled oligonucleotide (52-mer) annealed to X174, a
molecule with a ssDNA/dsDNA junction (2). In Fig. 6B, we
show a similar experiment using M13 annealed to the shorter
H2 (24-mer) oligonucleotide. Dna2 alone cleaves the circular
substrate but does not displace the oligonucleotide, as expected
(Fig. 6B, lanes 4 and 6). In the presence of RPA, however, we
could not assess endonuclease activity, because, surprisingly, in
the presence of both RPA and high levels of Dna2 (Fig. 6B, lanes
5 and 7), the entire labeled oligonucleotide was displaced. This
displacement is due to yet another form of interaction between
RPA and Dna2 because neither RPA (Fig. 6B, lane 3) nor Dna2
alone (Fig. 6B, lanes 4 and 6) displaces the oligonucleotide.
Therefore, we conclude that RPA inhibits the endonuclease
activity of Dna2 and that RPA and Dna2 can together destabi-
lize partial duplex DNA in the absence of ATP.
DISCUSSION
In this study, we have established that the Dna2 enzyme
exhibits true endonuclease activity. Unlike the well character-
ized flap endo/exonuclease function and helicase activity, the
Dna2 endonuclease does not require a free ssDNA end.
Although the endonuclease and flap endo/exonuclease appear
to share an active site, assays with the cofactorMn2 show that
these two functions are distinguishable.
The physiological significance of the endonuclease activity is
unclear. The ability to cut ssDNA internally could conceivably
result in a DSB at sites of DNA damage or between nascent
Okazaki fragments. Therefore, the endonuclease activity must
be somehow regulated. In the cell, long stretches of ssDNA
would be bound by RPA, and we have shown that RPA inhibits
the endonuclease on circular ssDNA in addition to circular
ssDNA with an annealed oligonucleotide. Although RPA stim-
ulates the Dna2 flap endo/exonuclease and RPA can be
removed from DNA by Dna2 without threading from an end
(33), RPA shows inhibitory effects on multiple Dna2 functions
in addition to the endonuclease (7, 12, 38). Other structural
features or participation of additional proteins in a complex at
the replication fork may also modulate the endonuclease activ-
ity, like the endonuclease of RecB in the RecBCD complex (39).
The need for regulation of this activity, however, should not
obscure the fact that endonuclease may, at times, be beneficial
because it could allow Dna2 to process intermediate structures
into a form compatible with its helicase and flap endo/exonu-
clease requirements. The helicase function of Dna2 as studied
in vitrowould imply that it is not important to cells because the
substrates are more likely to be cut by the flap endo/exonu-
clease than unwound. However, genetic experiments show that
the helicase activity does play a role in the survival of damage in
vivo (4).
Roles for the endonuclease may be hard to discern because
mutants are also defective in flap endo/exonuclease activity.
The observation that the two activities are distinguishable using
the cofactor Mn2 provides an approach to elucidate the con-
tributions of the endonuclease function to Okazaki fragment
processing or DBS resection in vitro. Future studies must also
address the role of post-translational modifications and other
proteins, especially Sgs1/BLM, in stimulating or inhibiting the
endonuclease function of Dna2 on both DNA repair interme-
diates and Okazaki fragment processing steps.
In reactions with Mn2, Dna2 exhibits helicase activity and
endonuclease activity as with Mg2. What is surprising is that
addition of Mn2 reveals an ATP-dependent exonuclease
activity, like that of the bacterial enzymes RecBCD and AddAB
FIGURE 6. Replication protein A inhibits Dna2 endonuclease. A, endonu-
clease reactions were performed as described under “Experimental Proce-
dures.” Briefly, RPA, 0, 0.75 g, or 1.5 g, was incubated with 100 ng of
M13mp18 ssDNA in endonuclease buffer containing 1 mM MgCl2 or 1 mM
MnCl2 as indicated, for 10 min at room temperature prior to the addition of
wild-type Dna2. Reactions were then incubated at 37 °C for 15 min, products
were resolved using electrophoresis on a 1% agarose gel, and DNA was
stainedwith ethidiumbromide. B, Dna2 and RPA together, but neither alone,
can displace short oligonucleotides annealed to M13mp18. 2.5 pmol of RPA
was incubated with radiolabeled H2 (fully annealed) oligonucleotide
annealed to M13mp18 ssDNA in 1 endonuclease/helicase buffer contain-
ing noNaCl for 10min at room temperature prior to the addition of wild-type
Dna2, 1mMMgCl2, and 1mMMnCl2 as indicated. Reactionswere incubated at
37 °C for 30min, and products were resolved by nondenaturing PAGE. Lane 1
shows the substrate after boiling to displace the oligonucleotide.
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(39–41). The nuclease domain of Dna2 shares some sequence
homology with RecB (32). The AddAB enzyme, like RecBCD, is
involved in DNA repair and homologous recombination with
dsDNA- and ssDNA-dependent ATPase, helicase, and ATP-
dependent endo- and exonuclease activities. Dna2 and AddAB
have also been proposed to share structural similarities in the
nuclease active site and in an iron staple domain spanning
the active site (42). Perhaps conformational changes in the
nuclease active site of Dna2 while bound to Mn2 cause Dna2
to behave more like these related enzymes. Weak ATP-depen-
dent nuclease has been seen previously with Dna2 in the pres-
ence ofMg2, but wasmost likely 3 exonuclease dependent on
ATP-driven helicase activity exposing a 3 ssDNA tail (32, 35,
43).
Functionally, the use ofMn2 as a cofactor in vitrowill allow
Dna2 to be studied under conditions that promote both heli-
case and flap endo/exonuclease strongly. Use has been made of
the ratio of cofactor to ATP in priming the Dna2 enzyme for
preferentially observing either helicase or nuclease activity,
respectively (31). However, the activity of the two domains is
likely to be coupled (35). In fact, genetic experiments show that
amutant with Dna2 helicase activity but not nuclease activity is
more sensitive to DSBs than a double helicase and nuclease-
deadmutant (19). Understanding how the two domainswork in
concert with each other andwith other enzymes present at sites
of DNA replication and repair will be important, however, to
understanding the role of Dna2 in genomic stability in a com-
prehensive fashion.
Although Mn2 is not as abundant in the cell as Mg2, sev-
eral enzymes are manganese-dependent (44–46). Prominent
among these is DSB-processing nuclease Mre11. Recently, the
purified Mre11-Rad50 complex from bacteriophage T4, which
also uses Mn2 as a divalent cation, was found to exhibit some
nuclease activity in Mg2 when assayed with proteins UvsY
(RAD52) and gp32 (RPA) (47). AswithDna2, the products from
the Mg2- and Mn2-catalyzed reactions were slightly differ-
ent. Another example of a manganese-dependent repair
enzyme is the latent endonuclease of human MutL, which is
critical in human mismatch repair (48).
Dna2 is one of the key players in eukaryotic DSB repair (8, 10,
11, 38). It is important to point out that human Mre11, one of
the stimulatory components of theDNAend resectionmachin-
ery, exhibits strictly Mn2-dependent endo- and exonuclease
activity in vitro (44). Substitution of Mg2 for Mn2 in DNA
end resection assays did not generate resection products (12).
Furthermore, addition of Mn2 to the Mg2-driven reactions
inhibited resection. It was suggested that this is due to inability
of one ormore of the proteins in the complex to function in the
presence of Mn2. Based on results presented here, the pres-
ence of Mn2 in the resection reactions should not have an
adverse effect with respect to Dna2 activity.
Changes in Dna2 active site conformation, and thus activity,
caused by Mn2 instead of Mg2 binding in vitro may mimic
a change in conformation when bound to other proteins in the
cell or when post-translationallymodified in vivo. These results
may have importance in studying higher order DNA-protein
complexes involving Dna2, a snapshot of which is provided by
the studies of DSB resection, referred to above, by Nimonkar et
al. (12). Detailed biochemical characterization of Dna2 will be
important for the design of in vitro reconstitution experiments
involving Dna2 in multiprotein complexes and dissection of
enzymatic activities and cofactor requirements of individual
components contributing to orderly and precise execution of
multistep replication/repair processes.
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